CATARACT PREVALENCE ESTIMATION AND FINANCIAL REQUIREMENTS FOR SURGERY UNMET NEEDS IN MEXICO- A SECONDARY SOURCES ANALYSIS
Author(s)
De leon M1, Sashka D2, Castañón I1, Ortiz A1, Gryzbowski E3, Kramis J3
1ALCON, CDMX, Mexico, 2ALCON a Novartis company, Distrito Federal, Mexico, 3Springer Health Care, México DF, Mexico
OBJECTIVES:: There is a lack in information in Mexico regarding to cataract prevalence estimation, unmeet surgery needs and resource allocation to meet this need. The aim of this study is to present the expected financial requirements to treat cataract in Mexico from the analysis of public secondary sources. METHODS:: Through a literature review and a critical analysis cataract prevalence (CP) was extracted from three different sources and were standardized to 2015 Intercensal National Survey, using assumptions we assessed the cataract patient affiliation, number of surgeries (NS) and access to health institutions; subsequently, a multi-scenario comparison was done for unmeet of cataract surgery (CS), its costs and the financial requirement in terms of public Health Expenditure (PHE). RESULTS:: The population of Mexico in 2015 is 119,530,753 applying reported rates and standardizing them to the population older than 65 years, prevalence varies from 6.2% to 8.2% (533,515; and 703,152, respectively) of which; 82% is covered by at least one of the institutions of the system. The NS reported by OCDE (83,868) has an associated cost of $53,738,040 USD; It is necessary to invest $280,913,188 USD to cover the unsatisfied demand of CS in affiliated population (438,416), which represents less than one percent (0.78%) of the PHE. CONCLUSIONS:: We found high heterogeneity in CP, CS reports, which may decrease the quality of the information recorded, however, if the different health care models remain as they are, the financial consequences would be catastrophic in terms of social cost and the pocket of users. The local data reported here, can help payers to establish best routes for resource allocation.
Conference/Value in Health Info
2017-09, ISPOR Latin America 2017, Sao Paulo, Brazil
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PSS7
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Sensory System Disorders